CPI-613 (Devimistat) IC50 for Cell-based and Cell-free Assays

CPI-613 (Devimistat) is a high-affinity OGDH, PDH, and DLD inhibitor. It affects TCA cycle and AMPK signaling by disrupting mitochondrial energy metabolism and increasing ROS production, effectively inhibiting tumor cell proliferation and inducing apoptosis.

🎯 check CPI-613 (Devimistat) product page